ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2019 American Transplant Congress

    Urinary Exosomal microRNA as a Non-Invasive Biomarker for the Diagnosis of Acute Rejection in Kidney Transplant Recipients

    J. Seo1, Y. Lee1, S. Jung1, Y. Kim1, J. Moon1, K. Jeong1, C. Kim2, J. Park3, B. Chung4, Y. Kim5, S. Lee1

    1Nephrology, Kyung Hee University College of Medicine, Seoul, Korea, Republic of, 2Nephrology, Kyungpook National University College of Medicine, Daegu, Korea, Republic of, 3Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of, 4Nephrology, The St. Mary’s Hospital of Catholic University of Korea, Seoul, Korea, Republic of, 5Nephrology, Inje University College of Medicine, Busan, Korea, Republic of

    *Purpose: Acute rejection (AR) is the main obstacle to the graft survival after kidney transplantation. Urinary exosome is a promising source of biomarker for various…
  • 2019 American Transplant Congress

    Rapid Detection of Kidney Transplant Injury by Quantifying Donor-Derived Cell-Free Deoxyribonucleic Acid via Massively Multiplex Polymerase Chain Reaction

    T. K. Sigdel1, F. Acosta2, S. Navarro2, B. Zimmermann2, Z. P. Demko2, S. Moshkevich2, P. R. Billings2, M. M. Sarwal1

    1University of California San Francisco, San Francisco, CA, 2Natera Inc., San Carlos, CA

    *Purpose: Plasma donor-derived cell-free DNA (dd-cfDNA) is a proven marker for allograft rejection in patients with kidney transplant (KT). Our goal was to assess performance…
  • 2019 American Transplant Congress

    NK Cell Quantification by Paraffin Immunohistochemistry is Not Predictive of Graft Outcome in 1-Year Surveillance Biopsies

    J. Barnes1, F. Suliman2, A. Shammout1, E. A. Farkash1

    1Pathology, Michigan Medicine, Ann Arbor, MI, 2Nephrology, Michigan Medicine, Ann Arbor, MI

    *Purpose: Molecular and animal studies have identified NK cells as important mediators and markers of antibody mediated rejection. Using three color immunohistochemistry for CD16, T-bet,…
  • 2019 American Transplant Congress

    Matrix Metalloproteinase-9 and Neutrophil Extracellular Traps in Human and Mouse Liver Ischemia and Reperfusion Injury

    S. Duarte, A. Zarrinpar, R. W. Busuttil, A. J. Coito

    Dumont-UCLA Transplant Center, Los Angeles, CA

    *Purpose: Neutrophils are key mediators of ischemia/reperfusion injury (IRI) in orthotopic liver transplantation (OLT). Once activated, they release nuclear DNA web-like structures called neutrophil extracellular…
  • 2019 American Transplant Congress

    Back Signaling of HLA Class I Molecules and NK Cell Receptor Ligands in Renal Epithelial Cells Contributes to the Rejection-Specific Microenvironment

    E. Chichelnitskiy1, J. Egelkamp1, K. Daemen1, J. Keil1, C. Neudörfl1, J. Bräsen2, J. Schmitz2, H. Haller3, C. Blume4, C. Falk5

    1Institute of Transplant Immunology, Hannover Medical School, Hannover, Germany, 2Nephropathology Unit, Institute of Pathology, Hannover Medical School, Hannover, Germany, 3Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany, 4Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany; Institute of Technical Chemistry, Leibniz University, Hannover, Germany, 5Institute of Transplant Immunology, Hannover Medical School; DZIF, German Center for Infection Research, TTU-IICH, Hannover/Braunschweig, Germany

    *Purpose: During the last years, diverse harming mechanisms of donor-specific antibodies (DSA) to endothelial cells have been studied accompanied by an emerging evidence of NK…
  • 2019 American Transplant Congress

    The Impact of KDPI on Post Transplant Kidney Function: Intercept versus Slope. A Single Center Study

    M. Molinari1, D. Jorgensen2, R. Mehta3, P. Sood3, A. Ganoza2, C. Puttarajappa3, R. Lopez2, M. Wijkstrom2, A. Tevar2, S. Hariharan3

    1University of Pittsburgh Medical Centre, Pittsburgh, PA, 2Surgery, University of Pittsburgh Medical Centre, Pittsburgh, PA, 3Medicine, University of Pittsburgh Medical Centre, Pittsburgh, PA

    *Purpose: We evaluated the impact of Kidney Donor Profile Index (KDPI) on post-transplant renal function and graft survival.*Methods: Between January-2013 and December- 2017, a total…
  • 2019 American Transplant Congress

    Long-Term Efficacy and Safety of Everolimus Based Immunosuppression on De Novo Kidney Transplantation with 10 Years Follow-Up

    Y. Watarai1, S. Narumi1, T. Tomosugi1, K. Futamura2, M. Okada1, M. Tsujita2, T. Hiramitsu1, T. Kobayashi3, N. Goto2

    1Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan, 2Transplant Nephrology, Nagoya Daini Red Cross Hospital, Nagoya, Japan, 3Kidney Transplantation, Aichi Medical University, Nagoya, Japan

    *Purpose: Long-term efficacy and safety of everolimus (EVR) based immunosuppression for de novo kidney transplant recipient who were involved in A1202 study from our institute…
  • 2019 American Transplant Congress

    Clinical Implications of Belatacept Conversion in a High-Risk, Urban Renal Transplant Population

    B. Valdepenas, J. Benken, E. Benedetti, Z. Hajjiri, A. Lichvar

    University of Illinois at Chicago, Chicago, IL

    *Purpose: Conversion to belatacept as maintenance immunosuppression has gained traction to prevent calcineurin inhibitor (CNI) induced toxicities in renal transplant (RTx) recipients. However, limited knowledge…
  • 2019 American Transplant Congress

    Calcineurin Inhibitor Holiday for Management of Post Transplant Acute Kidney Injury

    S. Sriperumbuduri, D. Lazarus, T. Fairhead, S. Hoar, J. Karpinski, G. Knoll

    Nephrology, The Ottawa hospital, Ottawa, ON, Canada

    *Purpose: Calcineurin inhibitors (CNI), despite dominating the armamentarium of post transplant medications, are associated with long term nephrotoxicity and also delayed recovery of renal function…
  • 2019 American Transplant Congress

    Long-Term Outcomes of Early Conversion to Sirolimus-Based Immunosuppression in Children with Living Donor Kidney Transplants

    B. Stotter1, S. Lui1, E. Weller2, L. Ganapathi1, M. Ferguson1, A. Traum1, M. Somers1, N. Rodig1

    1Pediatrics, Boston Children's Hospital, Boston, MA, 2Biostatistics and Research Design Center, Boston Children's Hospital, Boston, MA

    *Purpose: Following kidney transplantation (KTx), calcineurin inhibitor (CNI)-based maintenance immunosuppression (IS) can be associated with nephrotoxicity and other complications including viral infections and malignancy. Mammalian…
  • « Previous Page
  • 1
  • …
  • 150
  • 151
  • 152
  • 153
  • 154
  • …
  • 214
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences